Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical myelography with iohexol.

B Kendall, J Stevens

    The British Journal of Radiology
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Iohexol (Omnipaque) is a safe and effective contrast agent for cervical myelography, achieving excellent visualization with minimal adverse effects in adult patients. This study confirms its utility across various myelographic procedures.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Examination of a newly developed mobile dry scrubber (DS) for coal mine dust control applications.

    Transactions of Society for Mining, Metallurgy, and Exploration, Inc·2017
    Same author

    Development of a roof bolter canopy air curtain for respirable dust control.

    Mining engineering·2017
    Same author

    Oceanic oxygenation events in the anoxic Ediacaran ocean.

    Geobiology·2016
    Same author

    A prospective study of "undiagnosed" isolated myelopathy: II. Value of magnetic resonance imaging, evoked potentials and CSF analysis.

    European journal of neurology·2013
    Same author

    Quantitative MRI detects abnormalities in relatives of patients with epilepsy and malformations of cortical development.

    NeuroImage·2003
    Same author

    Ultra-fast low-angle rapid acquisition and relaxation enhancement (UFLARE) in patients with epilepsy.

    Neuroradiology·2002
    Same journal

    Radioligand therapy for paediatric patients with solid tumours.

    The British journal of radiology·2026
    Same journal

    Vertebral computed tomography attenuation to case-find low bone density in people undergoing lung cancer screening.

    The British journal of radiology·2026
    Same journal

    Machine learning models using 18F-FDG PET/CT radiomics for RAS mutation prediction and prognostic stratification in colorectal cancer.

    The British journal of radiology·2026
    Same journal

    Predictors of Relapse in Oligometastatic Prostate Patients Receiving Stereotactic Ablative Radiotherapy.

    The British journal of radiology·2026
    Same journal

    An Evaluation of Radiotherapy and Response in the Management of Perivascular Epithelioid Cell Tumors.

    The British journal of radiology·2026
    Same journal

    Ensuring radiology reporting quality across a national lung cancer screening programme.

    The British journal of radiology·2026
    See all related articles

    Area of Science:

    • Radiology
    • Neuroradiology
    • Medical Imaging

    Background:

    • Cervical myelography is a diagnostic imaging technique used to evaluate the spinal cord and nerve roots in the neck.
    • The selection of an appropriate contrast agent is crucial for achieving optimal image quality and patient safety during myelography.

    Purpose of the Study:

    • To evaluate the safety and efficacy of iohexol (Omnipaque) 300 mg I/ml for cervical myelography in adult patients.
    • To assess the diagnostic quality of images obtained using iohexol and document any adverse events.

    Main Methods:

    • An open, non-comparative study was conducted involving 68 adult patients undergoing cervical myelography.
    • Iohexol (Omnipaque) at a concentration of 300 mg I/ml was used as the contrast agent.
    • Electroencephalography (EEG) was performed on 39 patients before and 24 hours after the procedure to monitor for neurological changes.

    Related Experiment Videos

    Main Results:

    • Satisfactory visualization of the cervical spinal structures was achieved in all 68 patients.
    • Minor adverse effects were reported in 13 patients (19%), including headache, neck/back pain, nausea, vomiting, dizziness, and nystagmus, with most being mild and transient.
    • EEG monitoring revealed no seizure activity or significant changes in the 39 patients studied.

    Conclusions:

    • Iohexol (Omnipaque) 300 mg I/ml is a highly satisfactory contrast agent for all types of cervical myelography.
    • The study demonstrates the safety and efficacy of iohexol, with a low incidence of mild and transient adverse effects.